FDA Advisory Cmte. Members Should Be Vetted For Opinions, GAO Says
Executive Summary
FDA's selection process for potential advisory committee members should consider the candidates' opinions on relevant topics, a General Accounting Office report recommends
You may also be interested in...
FDA Under Scrutiny: Congress Presses Agency On Antidepressants, Plan B
Congress is asking FDA to document its actions in two high-profile agency decisions
FDA Reproductive Health Cmte. Line-Up Set; First Priority Will Be WHI Results
The new roster of FDA's Reproductive Health Drugs Advisory Committee includes two members who have conducted research or educational activities on hormone replacement therapy sponsored by Wyeth
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011